Product Code: GVR-2-68038-833-6
Diabetic Footwear Market Growth & Trends:
The global diabetic footwear market size is expected to reach USD 13.98 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.7% from 2025 to 2030. Rising importance of specialty footwear which improve the lower body posture and protect the feet from fungal infection is expected to remain a favorable factor. Furthermore, rising concerns over adverse effects associated with obesity are expected to promote the use of diabetic footwear as a preventive measure.
Shoes are expected to generate a revenue of USD 4.68 billion by 2030. The segment is expected to lead the market in light of its increased utility among office-going population. Furthermore, fluctuating diet patterns and hectic lifestyle among middle class population in emerging economies including China and India is expected to encourage consumers to use diabetic shoes as a regular footwear option.
Diabetic Footwear Market Report Highlights:
- The sandal segment is expected to grow at a significant CAGR during the forecast period, owing to increased usage of these products as casual footwear by people in the age group of 45+ in developed economies including Germany and U.K.
- Slippers generated a revenue of USD 3.22 billion in 2024. The segment is expected to hold more than 36.0% of global market share on account of predominant usage as daily home footwear among health conscious consumers
- Online segment is expected to remain the most lucrative distribution channel over the next eight years. These channels are expected to remain a preferred choice on account of various value-added benefits including cash benefits and free-home delivery by the footwear companies and e-commerce portals
- The North American diabetic footwear market secured the dominant market revenue share of 33.5% in 2024.
- The diabetic footwear market is highly competitive in nature with the main players including DJO Global Inc.; Drew Shoes; I-Runner; and Dr. Zen Products, Inc. Various manufacturers are concentrating on new product launches, capacity expansion, and technological innovation to cater to the existing and future demand from new application segments.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Diabetic Footwear Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Profit Margin Analysis (Industry-level)
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Diabetic Footwear Market: Product Estimates & Trend Analysis
- 4.1. Diabetic Footwear Market, By Product: Key Takeaways
- 4.2. Product Movement Analysis & Market Share, 2024 & 2030
- 4.3. Market Estimates & Forecasts, By Product, 2018 - 2030 (USD Billion)
- 4.3.1. Shoes
- 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Sandals
- 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Slippers
- 4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Diabetic Footwear Market: Distribution Channel Estimates & Trend Analysis
- 5.1. Diabetic Footwear, by Distribution Channel: Key Takeaways
- 5.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 5.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
- 5.3.1. Online
- 5.3.1.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Offline
- 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Diabetic Footwear Market: Regional Estimates & Trend Analysis
- 6.1. Diabetic Footwear Market: Regional Outlook
- 6.2. Regional Marketplaces: Key Takeaways
- 6.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
- 6.3.1. North America
- 6.3.1.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.1.2. U.S.
- 6.3.1.2.1. Key country dynamics
- 6.3.1.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.1.3. Canada
- 6.3.1.3.1. Key country dynamics
- 6.3.1.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.1.4. Mexico
- 6.3.1.4.1. Key country dynamics
- 6.3.1.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Europe
- 6.3.2.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2.2. U.K.
- 6.3.2.2.1. Key country dynamics
- 6.3.2.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2.3. Germany
- 6.3.2.3.1. Key country dynamics
- 6.3.2.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2.4. France
- 6.3.2.4.1. Key country dynamics
- 6.3.2.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2.5. Italy
- 6.3.2.5.1. Key country dynamics
- 6.3.2.5.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2.6. Spain
- 6.3.2.6.1. Key country dynamics
- 6.3.2.6.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Asia Pacific
- 6.3.3.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3.2. China
- 6.3.3.2.1. Key country dynamics
- 6.3.3.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3.3. Japan
- 6.3.3.3.1. Key country dynamics
- 6.3.3.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3.4. India
- 6.3.3.4.1. Key country dynamics
- 6.3.3.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Latin America
- 6.3.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4.2. Brazil
- 6.3.4.2.1. Key country dynamics
- 6.3.4.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Middle East and Africa
- 6.3.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5.2. Saudi Arabia
- 6.3.5.2.1. Key country dynamics
- 6.3.5.2.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5.3. UAE
- 6.3.5.3.1. Key country dynamics
- 6.3.5.3.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5.4. South Africa
- 6.3.5.4.1. Key country dynamics
- 6.3.5.4.2. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis by Key Market Participants
- 7.2. Company Categorization
- 7.3. Participant's Overview
- 7.4. Financial Performance
- 7.5. Product Benchmarking
- 7.6. Company Heat Map Analysis
- 7.7. Strategy Mapping
- 7.8. Company Profiles
- 7.8.1. Etonic Worldwide LLC
- 7.8.1.1. Company Overview
- 7.8.1.2. Financial Performance
- 7.8.1.3. Product Portfolios
- 7.8.1.4. Strategic Initiatives
- 7.8.2. Podartis srl
- 7.8.2.1. Company Overview
- 7.8.2.2. Financial Performance
- 7.8.2.3. Product Portfolios
- 7.8.2.4. Strategic Initiatives
- 7.8.3. DARCO International Inc.
- 7.8.3.1. Company Overview
- 7.8.3.2. Financial Performance
- 7.8.3.3. Product Portfolios
- 7.8.3.4. Strategic Initiatives
- 7.8.4. Aetrex Worldwide Inc.
- 7.8.4.1. Company Overview
- 7.8.4.2. Financial Performance
- 7.8.4.3. Product Portfolios
- 7.8.4.4. Strategic Initiatives
- 7.8.5. Apex Foot Health Industries LLC
- 7.8.5.1. Company Overview
- 7.8.5.2. Financial Performance
- 7.8.5.3. Product Portfolios
- 7.8.5.4. Strategic Initiatives
- 7.8.6. Advance Diabetic Solutions
- 7.8.6.1. Company Overview
- 7.8.6.2. Financial Performance
- 7.8.6.3. Product Portfolios
- 7.8.6.4. Strategic Initiatives
- 7.8.7. Dr. Comfort LLC
- 7.8.7.1. Company Overview
- 7.8.7.2. Financial Performance
- 7.8.7.3. Product Portfolios
- 7.8.7.4. Strategic Initiatives
- 7.8.8. Dr. Zen Products, Inc.
- 7.8.8.1. Company Overview
- 7.8.8.2. Financial Performance
- 7.8.8.3. Product Portfolios
- 7.8.8.4. Strategic Initiatives
- 7.8.9. Drew Shoe Corporation
- 7.8.9.1. Company Overview
- 7.8.9.2. Financial Performance
- 7.8.9.3. Product Portfolios
- 7.8.9.4. Strategic Initiatives
- 7.8.10. Orthofeet Inc.
- 7.8.10.1. Company Overview
- 7.8.10.2. Financial Performance
- 7.8.10.3. Product Portfolios
- 7.8.10.4. Strategic Initiatives